Showing 65–80 of 120 results
-

50mgHPLC99.548%
$255
NA Selank 50 mg is indicated for higher-dose neuromodulation studies. It influences central nervous system homeostasis by regulating neuropeptide signaling and GABA pathways. Research into its mechanism aids in understanding the dose-dependent characteristics of emotional regulation and neural balance, holding significant research value in the field of neuroscience.
View COA (Certificate of Analysis)
-

-

-

500mgHPLC99.147%
$76
Nicotinamide adenine dinucleotide (NAD+), a key molecule widely present in living organisms, plays a vital role in maintaining health and extending lifespan. It serves a central role in cellular energy metabolism, supporting the normal functioning of cells, while also participating in DNA repair and cellular protection to help defend against oxidative stress and cellular damage. The advantages of NAD+ lie in its ability to activate anti-aging related factors, promote cell repair and regeneration, delay the aging process, enhance immunity, improve metabolic health, and exhibit positive effects in cardiovascular protection, neuroprotection, and other aspects. Its significance extends beyond maintaining daily health, as it also provides new possibilities for anti-aging and disease prevention.
View COA (Certificate of Analysis)
-

20mgHPLC99.177%
$130
Ovagen is a substance with specific biological activity. Its core components include peptide complexes composed of specific amino acids (such as the AC-3 complex containing glutamic acid, aspartic acid, and leucine). It is a formulation capable of regulating physiological functions in living organisms.
View COA (Certificate of Analysis)
-

-

-

10mgHPLC99.935%
$80
The peptide PE 22-28 is a 7-amino-acid peptide designed based on research into the endogenous peptide Spadin (PE 12-28), which exhibits antidepressant activity. PE 22-28 is a synthetic peptide composed of seven amino acids and serves as a short peptide analog.
View COA (Certificate of Analysis)
-

20mgHPLC99.259%
$130
Pinealon is a synthetic peptide composed of three amino acids (glutamic acid, aspartic acid, and arginine), which has a wide range of biological activities.
View COA (Certificate of Analysis)
-

30mgHPLC99.621%
$400
PNC-27 is a chimeric p53 penetrating peptide consisting of a structural domain (residues 12-26) in the p53 protein that binds to HDM-2 and a transmembrane penetrating peptide sequence. It forms a transmembrane pore by binding to HDM-2 protein in cancer cell membranes, leading to membrane lysis and necrosis of cancer cells, while being non-toxic to normal cells. This selective mechanism has led to significant anticancer activity in a variety of cancer cells (e.g., breast cancer, pancreatic cancer, acute myeloid leukemia, etc.). PNC-27 is unique in that its mechanism of action does not depend on the functional state of p53, which makes it potentially advantageous for the treatment of tumors that are refractory to conventional p53-dependent therapies. In addition, PNC-27 has shown synergistic effects with chemotherapeutic agents such as paclitaxel, further enhancing its therapeutic potential.
View COA (Certificate of Analysis)
-

20mgHPLC99.793%
$130
Prostamax is a synthetic tetrapeptide belonging to the Khavinson peptide family. Prostamax has a specific molecular structure and biological activity, and it can regulate cellular processes such as metabolism, proliferation, and differentiation by binding to receptors on the cell surface or directly entering the cell, thereby having a positive impact on the health status of the prostate.
View COA (Certificate of Analysis)
-

10mgHPLC99.561%
$86
PT 141 (Bremelanotide) is a synthetic cyclic heptapeptide drug that shows unique potential in the treatment of sexual dysfunction. Its development stems from the unremitting efforts of researchers to improve the quality of life of patients with sexual dysfunction. After years of research and experimentation, it has gradually come into the public view.
View COA (Certificate of Analysis)
-

50mgHPLC99.782%
$234
Retatrutide is a novel peptide drug. As a triple receptor agonist, it acts on the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously. It helps individuals lose weight by comprehensively regulating appetite, enhancing satiety, suppressing hunger, and increasing energy expenditure.
View COA (Certificate of Analysis)
-

10mgHPLC99.453%
$62
Retatrutide is a novel peptide-based drug that functions as a triple receptor agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. It facilitates weight loss through comprehensive regulation of appetite by enhancing satiety, suppressing hunger, and increasing energy expenditure. Additionally, Retatrutide demonstrates significant improvements in multiple cardiometabolic risk indicators including blood pressure, glycated hemoglobin (HbA1c), fasting blood glucose, insulin levels, total cholesterol, LDL cholesterol, and triglycerides. It also exerts positive effects on patients with non-alcoholic fatty liver disease (NAFLD), normalizing hepatic fat content in the majority of participants.
View COA (Certificate of Analysis)
-

20mgHPLC99.292%
$105
Retatrutide is a novel peptide-based drug belonging to the class of triple receptor agonists targeting GLP-1R/GIPR/GCGR, composed of 39 amino acids. Its design is inspired by endogenous intestinal insulin-like hormones (such as GIP) and, through structural optimization, it can simultaneously activate the GLP-1 receptor (GLP-1R), GIP receptor (GIPR), and glucagon receptor (GCGR). Activating GLP-1R promotes insulin secretion, inhibits glucagon release, lowers blood glucose levels, delays gastric emptying, and reduces appetite; activating GIPR enhances insulin secretion effects, further lowers blood glucose levels, and also plays a role in lipid metabolism; activating GCGR promotes energy expenditure, enhances hepatic gluconeogenesis inhibition, and reduces hepatic fat deposition.
View COA (Certificate of Analysis)
-

30mgHPLC99.730%
$158
Retatrutide is a novel peptide drug. As a triple receptor agonist, it acts on the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously. It helps individuals lose weight by comprehensively regulating appetite, enhancing satiety, suppressing hunger, and increasing energy expenditure.
View COA (Certificate of Analysis)